Sensus Healthcare financials
$3.07+2.50%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.3M | $3.4M | $4.9M | $6.9M | $7.3M | $8.3M | $13.1M | $8.8M | $9.2M | $10.7M | $12.6M | $3.9M |
| Gross profit | $769.0K | $991.0K | $1.9M | $2.7M | $2.9M | $4.4M | $7.1M | $5.2M | $5.4M | $6.7M | $7.8M | $2.0M |
| Gross margin | 33.6% | 29.2% | 38.4% | 39.4% | 39.7% | 52.2% | 54.4% | 59.3% | 58.7% | 62.5% | 62.3% | 51.0% |
| Operating income | -$3.2M | -$4.4M | -$3.1M | -$2.6M | -$1.9M | -$2.6M | $1.7M | $1.5M | $2.0M | $2.9M | $5.6M | -$1.9M |
| Net income | -$8.7M | -$2.6M | -$3.2M | -$943.0K | -$1.0M | -$2.6M | $1.5M | $1.2M | $1.6M | $2.3M | $4.2M | -$1.5M |
| Net margin | −382.1% | −77.4% | −64.1% | −13.7% | −14.2% | −30.8% | 11.8% | 13.7% | 17.4% | 21.3% | 33.5% | −37.2% |
| Diluted EPS | $-0.53 | $-0.16 | $-0.19 | $-0.06 | $-0.06 | $-0.16 | $0.09 | $0.07 | $0.10 | $0.14 | $0.26 | $-0.09 |
| EBITDA | -$3.1M | -$4.3M | -$3.0M | -$2.5M | -$1.8M | -$2.6M | $1.8M | $1.5M | $2.0M | $3.0M | $5.6M | -$1.8M |
| Operating cash flow | -$3.1M | -$3.8M | -$2.2M | $2.3M | $3.1M | -$2.7M | -$827.0K | $4.0M | $4.2M | -$8.2M | $2.7M | $442.0K |
| Free cash flow | -$3.1M | -$3.8M | -$2.4M | $2.3M | $3.1M | -$2.7M | -$1.1M | $3.6M | $4.2M | -$8.4M | $2.7M | $431.0K |
| Diluted shares | 16.5M | 16.5M | 16.3M | 16.3M | 16.3M | 16.3M | 16.4M | 16.3M | 16.3M | 16.3M | 16.3M | 16.3M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $15.2M | $18.3M | $22.1M | $24.5M | $22.2M | $19.1M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $41.3M | $51.5M | $53.0M | $58.3M | $58.9M | $60.2M |
| Total liabilities | $4.4M | $6.0M | $4.9M | $7.1M | $6.8M | $7.2M |
| Shareholders' equity | $36.9M | $45.5M | $48.1M | $51.2M | $52.1M | $53.0M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology